Insight

  • Live forever report part three: Dr Cherry Lo

    Dr Cherry Lo, longevity advisor to supplement brand Manapura shares her thoughts with Agetech World in our on-going “Living Forever” series  "When Elon Musk speaks of 'reprogramming,' he is essentially identifying ageing as a solvable engineering issue. He believes we can overcome the fatal biological breakdowns by delivering biological 'OTA updates'. To understand why the ‘system’ eventually [...]

  • Live Forever report part two: Dr Halland Chen

    This month Agetech World is running a special 'Live Forever' series focusing on the future. What does healthy lifespan look like, and how long can it last? In part two we hear from Dr Halland Chen, a double board-certified Physician specialising in longevity medicine, cellular health, and biotech innovation. In an interview with Agetech World [...]

  • Special report: Can humankind really live forever?

    This month Agetech World is focusing on the future. What does healthy lifespan look like, and how long can it last? Our introductory article in this special series looks at the ‘biohacking’ quest to re-engineer ageing - and who it will benefit? Click below to read Agetech World editor Peter McCusker's report now.     [...]

  • Alzheimer’s mutation may delay disease onset

    An Alzheimer's mutation may delay disease onset by about 20 years in people otherwise expected to develop memory loss in their mid-40s. The mutation affects a protein called reelin, which directs brain cells to break down amyloid plaques and tau tangles, harmful protein build-ups linked to Alzheimer's. New research suggests the mutation makes reelin work [...]

  • The Agetech World research roundup

    Super-ageing key, Seaweed’s special, hair-raising breakthrough and more The secret of how ‘super-agers’ have the mental agility of people decades younger is centred around brain health, say US researchers. Some elderly people are able to regenerate brain cells twice as quickly as other, healthy adults, of the same age. While it has recently been established [...]

  • Low-dose lithium may slow Alzheimer’s verbal memory decline

    Low-dose lithium may slow verbal memory decline linked to Alzheimer’s disease in older adults, according to a pilot clinical trial. The two-year trial enrolled adults aged 60 and older with mild cognitive impairment, a condition where people develop noticeable memory or thinking problems beyond what is typical for their age. Participants were randomly assigned to [...]

  • Listening to music may lower dementia risk, study suggests

    Listening to or playing music regularly may lower dementia risk in adults over 70, according to research tracking more than 10,800 people. A study of more than 10,800 adults aged over 70 found those who listened to music most days had a 39 per cent lower likelihood of developing dementia than people who sometimes, rarely [...]

  • Agetech investment and innovation round-up

    Global market to hit US$740bn in 2026, longevity needs lifts? ‘little brain’s’ big role, ageing ethics questioned…and more IRISH insight and analysis company Research and Markets estimates the global ageing economy will surpass US$740bn this year. These projections by the company, which is based next to the Guinness Brewery in Dublin, come in its latest [...]

  • Centenarians’ blood reveals longevity clues

    Centenarians’ blood contains 37 proteins linked to slower ageing, with profiles closer to younger adults than to octogenarians, according to new research. In Switzerland, around 0.02 per cent of the population lives beyond 100. As part of the SWISS100 project, researchers compared blood samples from centenarians, octogenarians and adults aged 30 to 60 to identify [...]

  • Interview: The US company appealing Europe’s rejection of daily Alzheimer’s pill

    Despite having its application for a new, daily Alzheimer’s pill rejected by Europe’s regulators the CEO of US drug company Anavex Life Sciences is appealing this decision. A Phase IIb/III trial  found over one-third of patients with mild Alzheimer’s - those with a Mini-Mental State Examination (MMSE) score of between 20 and 28 - experienced [...]